Lutathera & pluvicto isotopes
Ended Awarded Last action
- Contract number
- 36C24425F0144
- Awardee
-
Advanced Accelerator Applications USA Inc. UEI JNM4NBNHFE66
- Awarding agency
-
Veterans Integrated Service Network 4
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $84,994
Award facts
- Contract value 100% obligated
- $84,993.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lebanon, PA 17042, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,849,979 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,934,973 |
About this award
Advanced Accelerator Applications USA Inc., a Novartis subsidiary and established supplier of specialized radiopharmaceutical products, has been awarded a delivery order valued at $84,993.58 by Veterans Integrated Service Network 4 (VISN 4), the Veterans Health Administration's regional healthcare network serving the Northeast. The delivery order, issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), covers LUTATHERA (lutetium Lu 177 dotatate) and PLUVICTO (lutetium Lu 177 vipivotide tetraxetan)—targeted radioligand therapies used in the treatment of neuroendocrine tumors and metastatic castration-resistant prostate cancer, respectively. The contract carries a firm fixed price structure with no small business set-aside designation and is scheduled for completion by December 31, 2025, with delivery and performance based in Lebanon, Pennsylvania.
This delivery order represents continued procurement activity under Advanced Accelerator Applications USA Inc.'s established blanket purchase agreements across multiple Veterans Integrated Service Networks. The company maintains substantial contract vehicles with the VA system, including a $49.1 million single-award BPA with VISN 9 and a $7.5 million BPA with VISN 21 for these same radiopharmaceutical products. The award reflects the Department of Veterans Affairs' ongoing commitment to providing advanced nuclear medicine therapeutic options to eligible veterans, with the company serving as the sole source supplier for these FDA-approved targeted therapies across the federal healthcare system.
Quick answers
Who was awarded contract 36C24425F0144?
36C24425F0144 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 4 (Veterans Health Administration) on January 1, 2025.
How much is contract 36C24425F0144 worth?
The government has obligated $84,994 on 36C24425F0144.
Is contract 36C24425F0144 an order under another contract?
Yes. 36C24425F0144 is a delivery order under 36F79719D0169, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24425F0144 competed?
The extent of competition for 36C24425F0144 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award